PLEASANTON, Calif.--(BUSINESS WIRE)--Diagnostic Biosystems (DBS), a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360™ System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents.
